4th International AIDS Society Conference on HIV Pathogenesis and Treatment Sydney, Australia - July 22 - 25, 2007

RESPONDING TO THE HIV EPIDEMIC AMONG INJECTION DRUG USERS IN VANCOUVER, CANADA: EVIDENCE OF BEST PRACTICE IN NEEDLE EXCHANGE TO PREVENT HIV RISK BEHAVIOUR

IAS Conf HIV Pathog Treat 2007 Jul 22-25;4th: Abstract No. MOAC205

Kerr T., Small W., Fair B., Wood E.
BC Centre for Excellence in HIV/AIDS, Vancouver, Canada

INTRODUCTION: Vancouver, Canada was the site of an explosive epidemic among injection drug users (IDU), despite the fact that Vancouver had a large needle exchange program (NEP) in operation. A series have studies have suggested that a number of programmatic deficiencies in the NEP limited the preventative effect of this program locally. In response, in 2000, regional health authorities began to decentralize and expand the NEP, and moved away from a focus on exchange toward a focus on distribution.

METHODS: Data concerning syringe sharing and difficulty in accessing sterile syringes for the period 1996-2002 was derived from the Vancouver Injection Drug Users Study (VIDUS), an open prospective cohort study involving over 1500 community-recruited IDU. Information concerning needle exchange policies and practices were obtained for the same period.

RESULTS: Significant changes in the policies governing the delivery of NEP were implemented in 2001, including removal of limits on the number of syringes distributed, and an increase in the number of sites providing syringes. This was accompanied by an initial increase in the total volume of syringes distributed, and declines in the proportion of IDU reporting difficulty accessing syringes (from 8.7% at baseline to 6.0% in 2002) and sharing syringes (from 48.9% at baseline to 8.5% in 2002).

CONCLUSIONS: Efforts to improve the delivery NEP services through expanded access and removal of limits on the number of syringes distributed was accompanied by declines in reports of difficulty accessing and syringe sharing. These findings have implications for best practices in HIV prevention for IDU. However, our findings indicate the need for additional complimentary policies and programs to address ongoing syringe sharing.

Download PDF of this abstract.

2007-07-22
MOAC205
Global Responses to HIV Prevention Among Injection Drug Users

Copyright © 2007 - International AIDS Society (IAS). All information and content relating to the abstracts from the 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, such as text, graphics, logos, button icons, images, audio clips, and software is protected by copyright. Permission is hereby granted for the non-commercial use or reproduction of the information on this web site, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.

AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. Permission is hereby granted for the non-commercial use or reproduction of the information herein, provided that the use of such information is accompanied by an acknowledgement that IAS is the source of the information and the name of the author of the article.